Company
Headquarters: Jakarta, Indonesia
Employees: 12,022
Rp3.757 Trillion
IDR as of July 1, 2025
US$232.2 Million
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and markets chemical, betalactam and non betalactam, antiretroviral, narcotic, hormone contraceptive, powder, oil castor, edible oil, cosmetic, over the counter, personal, and beauty care products, as well as food supplements, active pharmaceutical ingredients, and medical devices. In addition, the company manufactures, markets, distributes, and trades in pharmaceutical products; and operates drug materials plants. As of December 31, 2020, it operated 1,278 retail pharmacy outlets, 451 health clinic outlets, 75 clinical laboratories, 10 optics, 3 beauty clinics, and 24 international retail outlets. The company sells its products to pharmacies, drug stores, hospitals, and free traders through pharmaceutical wholesalers. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.
PT Kimia Farma has the following listings and related stock indices.
Stock: IDX: KAEF wb_incandescent
Stock: Munich: HQP wb_incandescent